
Exact Sciences Corporation EXAS
Annual report 2025
added 02-13-2026
Exact Sciences Corporation P/CF Ratio 2011-2026 | EXAS
Annual P/CF Ratio Exact Sciences Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 39.7 | 44 | 71.8 | -48.7 | -128 | 152 | -42.8 | -48.8 | -40.6 | -12.8 | -3.88 | -23.4 | -18.6 | -14.4 | -16 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 152 | -128 | -6.03 |
P/CF Ratio of other stocks in the Diagnostics research industry
| Issuer | P/CF Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
26.1 | - | -6.23 % | $ 30.6 M | ||
|
Agilent Technologies
A
|
28.3 | $ 115.93 | 0.34 % | $ 35.2 B | ||
|
Akumin
AKU
|
1.15 | - | -17.87 % | $ 25.9 M | ||
|
Accelerate Diagnostics
AXDX
|
-0.826 | - | -61.36 % | $ 2.46 M | ||
|
Co-Diagnostics
CODX
|
-0.201 | $ 1.67 | - | $ 2.22 M | ||
|
Aspira Women's Health
AWH
|
-1.41 | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
-0.447 | - | -13.05 % | $ 7.29 M | ||
|
Castle Biosciences
CSTL
|
10.9 | $ 25.24 | 3.19 % | $ 701 M | ||
|
Chembio Diagnostics
CEMI
|
-0.991 | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
-0.541 | - | - | $ 9.42 M | ||
|
CareDx, Inc
CDNA
|
23.6 | $ 21.47 | 1.13 % | $ 1.14 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
-47.7 | - | - | $ 562 M | ||
|
DermTech
DMTK
|
-0.551 | - | -11.32 % | $ 2.94 M | ||
|
Illumina
ILMN
|
19.6 | $ 127.5 | -0.3 % | $ 20.3 B | ||
|
Enzo Biochem
ENZ
|
-0.00219 | - | -8.98 % | $ 14.8 K | ||
|
Fulgent Genetics
FLGT
|
22.2 | $ 16.0 | -1.9 % | $ 484 M | ||
|
Global Cord Blood Corporation
CO
|
0.396 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-17.1 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-1.63 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-2.94 | - | 0.12 % | $ 80.1 M | ||
|
Charles River Laboratories International
CRL
|
10.4 | $ 173.04 | 1.93 % | $ 8.58 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
21.8 | - | - | $ 10.7 B | ||
|
Lantheus Holdings
LNTH
|
13.1 | $ 84.45 | 0.14 % | $ 5.7 B | ||
|
Guardant Health
GH
|
-72.7 | $ 89.29 | 0.43 % | $ 11.2 B | ||
|
Medpace Holdings
MEDP
|
18.2 | $ 415.78 | 1.28 % | $ 12 B | ||
|
HTG Molecular Diagnostics
HTGM
|
-0.162 | - | -20.0 % | $ 1.06 M | ||
|
Heska Corporation
HSKA
|
-38.7 | - | - | $ 1.31 B | ||
|
Interpace Biosciences
IDXG
|
1.26 | $ 1.91 | -3.29 % | $ 8.45 M | ||
|
Koninklijke Philips N.V.
PHG
|
26.5 | $ 27.59 | 0.42 % | $ 20 B | ||
|
Motus GI Holdings
MOTS
|
-0.0884 | - | -34.28 % | $ 263 K | ||
|
Senseonics Holdings
SENS
|
-5.93 | $ 7.08 | 0.35 % | $ 295 M | ||
|
QIAGEN N.V.
QGEN
|
12.6 | - | - | $ 10.6 B | ||
|
Soleno Therapeutics
SLNO
|
44.5 | $ 52.73 | 0.01 % | $ 2.68 B | ||
|
Neogen Corporation
NEOG
|
17.5 | $ 9.51 | -0.37 % | $ 2.06 B | ||
|
Biomerica
BMRA
|
-1.87 | $ 2.16 | 0.93 % | $ 4.96 M | ||
|
National Research Corporation
NRC
|
11.9 | $ 17.21 | -0.12 % | $ 385 M | ||
|
ICON Public Limited Company
ICLR
|
12.9 | $ 100.91 | -1.24 % | $ 8.32 B | ||
|
Laboratory Corporation of America Holdings
LH
|
14.6 | $ 263.12 | -0.24 % | $ 21.9 B | ||
|
Thermo Fisher Scientific
TMO
|
25.1 | $ 467.91 | -0.35 % | $ 176 B | ||
|
Celcuity
CELC
|
-35 | $ 122.2 | 0.96 % | $ 5.71 B | ||
|
Trinity Biotech plc
TRIB
|
9.03 | $ 0.64 | -1.51 % | $ 61.9 M | ||
|
OpGen
OPGN
|
-1.87 | - | -16.95 % | $ 1.54 M | ||
|
NeoGenomics
NEO
|
284 | $ 8.54 | 3.02 % | $ 1.09 B | ||
|
Twist Bioscience Corporation
TWST
|
-32.8 | $ 60.33 | -1.0 % | $ 3.61 B | ||
|
Myriad Genetics
MYGN
|
227 | $ 4.8 | 0.31 % | $ 444 M | ||
|
Natera
NTRA
|
-12.3 | $ 204.58 | 0.41 % | $ 20.1 B | ||
|
Quest Diagnostics Incorporated
DGX
|
12.4 | $ 196.1 | -0.06 % | $ 21.8 B | ||
|
Invitae Corporation
NVTA
|
-1.04 | - | - | $ 21.2 M | ||
|
PerkinElmer
PKI
|
22.5 | - | -0.91 % | $ 14.7 B |